Choice Defines QALYs A US Valuation of the EQ-5D-5L

被引:37
|
作者
Craig, Benjamin M. [1 ]
Rand, Kim [2 ,3 ]
机构
[1] Univ S Florida, Dept Econ, 4202 E Fowler Ave,CMC206A, Tampa, FL 33620 USA
[2] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[3] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
基金
美国国家卫生研究院;
关键词
quality-adjusted life years; patient preference; choice behavior; health valuation; cost-utility analyses; value of life; quality of life; patient reported outcome measures; TIME TRADE-OFF; SUBJECTIVE HEALTH OUTCOMES; UNITED-STATES; VALUE SET; PREFERENCE RESEARCH; VALUES; TTO; DURATION; ADULTS; MODEL;
D O I
10.1097/MLR.0000000000000912
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The 5-level version of the EQ-5D (EQ-5D-5L) was introduced as an improvement on the original 3-level version (EQ-5D-3L). To date, 6 country-specific value sets have been published for EQ-5D-5L and 9 US value sets have been published for other instruments. Our aims were to (1) produce EQ-5D-5L values on a quality-adjusted life year (QALY) scale from the perspective of US adults and (2) compare them with US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Methods: In 2016, 8222 US respondents from all 50 states and Washington, DC completed an online survey including a discrete choice experiment with 20 paired comparisons. Each comparison asked respondents, "Which do you prefer?" regarding a pair of alternatives described using EQ-5D-5L and lifespan attributes. On the basis of more than 50 choices on each of the 3160 pairs, we estimated EQ-5D-5L values on a QALY scale and compared them with the US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Results: Ranging from -0.287 (55555) to 0.992 (11121) on a QALY scale, the estimated EQ-5D-5L values were similar to the US EQ-5D-3L values. Compared with the US EQ-5D-3L values, the values exhibited greater sensitivity and specificity and higher correlation with the EQ-5D-5L values of other countries, particularly England. Conclusions: Like previous US valuation studies, this study produced nationally representative EQ-5D-5L values on a QALY scale. The results further demonstrate the advantages of the EQ-5D-5L over its 3-level predecessor as a preference-based summary measure of health-related quality of life from the perspective of US adults.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 50 条
  • [31] RETRACTED: The EQ-5D-5L Valuation Study in Egypt (Retracted Article)
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    [J]. PHARMACOECONOMICS, 2021, 39 (05) : 549 - 561
  • [32] Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of cTTO and DCE
    Augustovski, Federico
    Belizan, Maria
    Gibbons, Luz
    Reyes, Nora
    Stolk, Elly
    Craig, Benjamin M.
    Tejada, Romina A.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (01): : 140 - 141
  • [33] COVID-19 and EQ-5D-5L health state valuation
    Edward J. D. Webb
    Paul Kind
    David Meads
    Adam Martin
    [J]. The European Journal of Health Economics, 2024, 25 : 117 - 145
  • [34] Valuing EQ-5D-5L: Comparing the Time Trade Off and Discrete Choice Experiment Valuation Methods
    Mulhern, Brendan
    Norman, Richard
    Street, Deborah
    Shah, Koonal
    Lancsar, Emily
    Ratcliffe, Julie
    Viney, Rosalie
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (01): : 140 - 140
  • [35] Quality control of the data on the Portuguese study for the valuation of the EQ-5D-5L
    Antunes, Patricia
    Ferreira, Pedro Lopes
    Ferreira, Lara Noronha
    Pereira, Luis
    [J]. QUALITY OF LIFE RESEARCH, 2018, 27 : S62 - S62
  • [36] Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets
    Law, Ernest H.
    Pickard, A. Simon
    Xie, Feng
    Walton, Surrey M.
    Lee, Todd A.
    Schwartz, Alan
    [J]. MEDICAL DECISION MAKING, 2018, 38 (08) : 968 - 982
  • [37] Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
    Rencz, Fanni
    Brodszky, Valentin
    Gulacsi, Laszlo
    Golicki, Dominik
    Ruzsa, Gabor
    Pickard, A. Simon
    Law, Ernest H.
    Pentek, Marta
    [J]. VALUE IN HEALTH, 2020, 23 (09) : 1235 - 1245
  • [38] Mapping EQ-5D-3L to EQ-5D-5L
    van Hout, Ben A.
    Shaw, James W.
    [J]. VALUE IN HEALTH, 2021, 24 (09) : 1285 - 1293
  • [39] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Thompson, Alexander James
    Turner, Alex James
    [J]. PHARMACOECONOMICS, 2020, 38 (06) : 575 - 591
  • [40] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Alexander James Thompson
    Alex James Turner
    [J]. PharmacoEconomics, 2020, 38 : 575 - 591